Association Between EGFR and ALK Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC

INTRODUCTION: After palliative radiotherapy for bone metastases from NSCLC, up to 30% of patients may derive no symptomatic benefit, and there are a lack of biological predictors for this. The purpose was to investigate whether EGFR and ALK genetic rearrangements were associated with greater rates o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sit, Daegan, Bale, Michelle, Lapointe, Vincent, Olson, Robert, Hsu, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356089/
https://www.ncbi.nlm.nih.gov/pubmed/35941996
http://dx.doi.org/10.1016/j.jtocrr.2022.100371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356089/
https://www.ncbi.nlm.nih.gov/pubmed/35941996
http://dx.doi.org/10.1016/j.jtocrr.2022.100371

Ejemplares similares